The best scientists and researchers throughout the world are endless invest all their energy in finding a vaccine to end the Corovirus novel pandemic which has affected more than 200 countries.
To provide assistance, a medical student from Emory University was one of the first people who volunteered for an event vaccine trials that doctors pin their hopes, to be the ones who end this global nightmare.
The 31-year-old PhD candidate, Sean Doyle, is in his fourth year of medical school and is compliant Daily MailHe received a trial dose last month. It was developed by the National Institutes of Health, and a biotech company based in Massachusetts, Moderna Inc.
Based on a USA TODAY reported, volunteers in Seattle had also registered for vaccine trials and now had moved to the second phase after there were reports that had only a slight side effect.
In addition, the report also added that the participants had no chance of being infected from the injection because they did not contain coronavirus itself. In contrast, synthetic messenger RNA (mRNA) is used to immunize viruses.
RNA is short for Ribonucleic acid and is a biological process that directs cells to produce something.
Such trials have potentially narrowing something to help the body be immunized fight viruses. The RNA vaccine will provoke cells to form spike proteins that resemble the structure of the coronavirus. If the experiment is successful, the body will be conditioned to recognize the surge protein and develop antibodies that can help protect against future infections.
However, as with all medical trials, RNA vaccines are not risk-free and there is no evidence of how well they will work in large groups of people.
Amesh Adalja from Johns Hopkins University said CNN“There is no precedent for them to be approved for use and, and we don’t know everything about them in terms of how they will behave in large numbers of people and what their side effect profile is like.”
Dr Adalja also added that developing vaccines usually takes years and sometimes, even decades. He said, “There are some infectious diseases that we don’t have vaccines after decades of work, such as HIV or hepatitis C, for example. The only way we truly contain this virus is with vaccines. “
Returning to medical students, Doyle told CNN that he was aware of all the risks he faced by participating in trials for unknown drugs. She says, “There are conversations that I have with friends and family. They all expressed concern about getting an experimental vaccine like this where no one knew what the side effects were. But they trusted my judgment. “
do not miss
Also, this is not the first time Doyle volunteered to be part of a medical experiment. Two and a half years ago, he was involved in an experiment for the Ebola virus where he was injected with experimental immunizations. In fact, his experience of the 18-month trial made him eligible for the COVID-19 trial.
He said, “Nobody is really sure how it will behave when put in your body. So some of my friends and family showed a little concern. But I am familiar with statistics about how rarely very severe reactions occur. So I’m not too worried about being negatively affected by participating in this trial. It seems that the benefits far outweigh any potential risks. “
Because SARS-CoV-2 is a highly contagious virus, scientists are trying to make the vaccine as fast as possible and the best scenario is aimed at 12 to 18 months.